Debra Patt, M.D., PhD, MBA, medical oncologist and executive vice president at Texas Oncology, discusses the alarming decline in lung cancer diagnoses in Texas, the serious implications this can have for patient outcomes, and the importance of seeking regular care during COVID-19 – especially for those at increased risk for lung cancer. According to the NCI, delays in cancer screenings, diagnoses, and treatment because of the COVID-19 pandemic will likely result in thousands of excess cancer deaths in the coming years.